Loading…
Novel electrochemical biosensing platform for microRNA detection based on G-quadruplex formation in nanochannels
[Display omitted] •A label-free electrochemical biosensing platform for microRNA was established.•Formation of G-quadruplex/hemin complex in nanochannels was performed.•A ultralow detection limit of 0.5 aM was obtained for MiR-21 detection. Ultrasensitive detection of microRNA is crucial important i...
Saved in:
Published in: | Sensors and actuators. B, Chemical Chemical, 2021-01, Vol.327, p.128898, Article 128898 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [Display omitted]
•A label-free electrochemical biosensing platform for microRNA was established.•Formation of G-quadruplex/hemin complex in nanochannels was performed.•A ultralow detection limit of 0.5 aM was obtained for MiR-21 detection.
Ultrasensitive detection of microRNA is crucial important in the diagnosis of related diseases. By immobilizing the capture probes in nanochannels, we developed a label-free electrochemical biosensing platform based on guanine-quadruplex (G-quadruplex) formation in nanochannels. The designed capture probe contains both the microRNA-21 (MiR-21) recognition sequence and guanine-rich sequence. The presence of the target MiR-21 would trigger the enzymatic cleaving of the RNA/DNA heteroduplexes which led some of the guanine-rich sequences escape from the nanochannels and thus reduced the formation of the G-quadruplex/hemin complex. Therefore, the quantity of methylene blue fluxed through the nanochannels changed because of the variation of the steric hindrance. A optimized carbon nanofibers modified electrode was applied to monitor the quantity difference of methylene blue. In this way, the biosensing platform realized the label-free electrochemical detection of MiR-21 with a ultralow detection limit of 0.5 aM. Meanwhile, this biosensing platform was assessed for MiR-21 detection in serum samples. The biosensing platform can be readily extended to the assay of other scarcetumor-related genes. |
---|---|
ISSN: | 0925-4005 1873-3077 |
DOI: | 10.1016/j.snb.2020.128898 |